STAT spoke to Medtronic CEO Geoff Martha about the company’s challenges in the diabetes and renal denervation markets, as well as his broader vision for teasing out innovative products.

Medtronic CEO talks latest bets on diabetes, high blood pressure technology

A district court has handed a preliminary injunction to EOFlow, blocking it from selling products developed using proprietary information derived from insulin pump maker Insulet — the decision arriving as Medtronic is slated to pay $738 million to acquire EOFlow.

Ongoing Insulin Pump Litigation Sees Court Hand Injunction to EOFlow

The list of draft documents touches on many topics the agency has discussed over the past year. Lifecycle management and premarket submissions for devices enabled by AI and machine learning top the list of drafts scheduled for publication in the coming ...

FDA prioritizes guidance on AI, cybersecurity, pulse oximeters in stacked schedule for 2024

New rules are coming that would limit emissions of ethylene oxide (EtO), a toxic, colorless gas used to sterilize medical devices. The Environmental Protection Agency is slated to issue a final rule by March, which the agency expects will reduce EtO ...

FDA: ‘We have had a very loud voice’ on EtO

A trial team at Panish | Shea | Boyle | Ravipudi won a $135 million damages verdict for two California men who were sexually abused by their sixth-grade teacher starting in 1996 in a case where the school district was on notice of other child molestation complaints against the teacher years earlier.

A Full Slate of Litigator of the Week Runners-Up and Shout Outs

Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.

Medtronic’s $738m deal with insulin maker at risk

Executives are faced with a tremendous obligation - to employees, communities, and shareholders - and an unparalleled opportunity. NORTHAMPTON, MA / ACCESSWIRE / October 11, 2023 / Medtronic Torod B. Neptune, Senior Vice President and Chief Communications ...

Medtronic: Transparency, Accountability, Commitment: Three Non-Negotiables for Responsible Business

At AdvaMed’s The MedTech Conference, Cataldo moderated a panel called “Medtech M&A: Trends, Strategies, and Opportunities.” It featured Medtronic CEO Geoff Martha, Zimmer Biomet SVP and Chief Strategy Officer Rachel Ellingson and Smith+Nephew CEO Deepak Nath.

How Medtronic, Zimmer Biomet and Smith+Nephew approach medtech M&A

Ahead of a planned acquisition by Medtronic, it’s not all smooth sailing for EOFlow. The South Korean company makes a waterproof, disposable insulin patch pump that can hold up to 3.5 days ...

Medtronic target EOFlow faces preliminary injunction as Insulet argues trade secrets case

The global wearable medical devices market size is expected to reach a market valuation of US$ 27.29 Billion by 2022, accelerating with a moderate CAGR of 28.1% by 2022 to 2032. The wearable medical devices market is anticipated to be valued at about US$ 73.

Wearable Medical Devices Market is projected to reach US$ 73.48 Billion by 2032 at a CAGR of 28.1% | FMI

A district court has handed a preliminary injunction to EOFlow, blocking it from selling products developed using proprietary information derived from insulin pump maker Insulet — the decision arriving as Medtronic is slated to pay $738 million to ...

Court Grants Injunction Against EOFlow in Ongoing Insulin Pump Litigation

A federal judge has blocked EOFlow, a company that Medtronic plans to acquire, from selling its insulin patch pump.

Insulet wins preliminary injunction against EOFlow in patent suit

EOFlow

In 2021, HackerNoon hosted the first-ever Startup of the Year awards!!

Meet the Winners of Startups in Asia

“The sun ruling both horizons, triumphant in the horizon in his name; the glittering splendor which is in the sun’s disc.”

THE SONG OF THE MOTH

Static site generators are the best way to produce a simple, secure, super fast website.

The simplest static site generator

EOPatch(Wearable Insulin Pump) Manufacturer

EOFLOW

eoflow.com

Since 2011

EOFLOW

EVERGREEN INDEX #4534

EOFlow's stories on HackerNoon

Meet the Winners of Startups in Asia

THE SONG OF THE MOTH

The simplest static site generator

EOFlow's latest news & mentions

Medtronic CEO talks latest bets on diabetes, high blood pressure technology

Ongoing Insulin Pump Litigation Sees Court Hand Injunction to EOFlow

FDA prioritizes guidance on AI, cybersecurity, pulse oximeters in stacked schedule for 2024

FDA: ‘We have had a very loud voice’ on EtO

A Full Slate of Litigator of the Week Runners-Up and Shout Outs

Medtronic’s $738m deal with insulin maker at risk

Medtronic: Transparency, Accountability, Commitment: Three Non-Negotiables for Responsible Business

How Medtronic, Zimmer Biomet and Smith+Nephew approach medtech M&A

Medtronic target EOFlow faces preliminary injunction as Insulet argues trade secrets case

Wearable Medical Devices Market is projected to reach US$ 73.48 Billion by 2032 at a CAGR of 28.1% | FMI

Court Grants Injunction Against EOFlow in Ongoing Insulin Pump Litigation

Insulet wins preliminary injunction against EOFlow in patent suit

EOFlow's Related Companies

Representing this company? Click here to claim and customize this page!

Reviews About EOFlow

EOFlow WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

Light-Mode

Classic

Newspaper

Dark-Mode

Neon Noir

Minty

HN StartUps

EOFLOW

eoflow.com

Since 2011

EOFLOW

EVERGREEN INDEX #4534

EOFlow's stories on HackerNoon

Meet the Winners of Startups in Asia

THE SONG OF THE MOTH

The simplest static site generator

EOFlow's latest news & mentions

Medtronic CEO talks latest bets on diabetes, high blood pressure technology

Ongoing Insulin Pump Litigation Sees Court Hand Injunction to EOFlow

FDA prioritizes guidance on AI, cybersecurity, pulse oximeters in stacked schedule for 2024

FDA: ‘We have had a very loud voice’ on EtO

A Full Slate of Litigator of the Week Runners-Up and Shout Outs

Medtronic’s $738m deal with insulin maker at risk

Medtronic: Transparency, Accountability, Commitment: Three Non-Negotiables for Responsible Business

How Medtronic, Zimmer Biomet and Smith+Nephew approach medtech M&A

Medtronic target EOFlow faces preliminary injunction as Insulet argues trade secrets case

Wearable Medical Devices Market is projected to reach US$ 73.48 Billion by 2032 at a CAGR of 28.1% | FMI

Court Grants Injunction Against EOFlow in Ongoing Insulin Pump Litigation

Insulet wins preliminary injunction against EOFlow in patent suit

EOFlow's Related Companies

80B

65B

7%

2013

2021

2019

-1%

2013

Representing this company? Click here to claim and customize this page!

Reviews About EOFlow

EOFlow WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

Light-Mode

Classic

Newspaper

Dark-Mode

Neon Noir

Minty

HN StartUps